Anna Lichota
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Fullerene Chemistry and Applications 4
- Quinazolinone synthesis and applications 1
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Krzysztof Gwoździński (5 shared papers)Łukasz Gwoździński (1 shared paper)Anita Krokosz (4 shared papers)Eligia M. Szewczyk (2 shared papers)Jacek Grębowski (1 shared paper)Mariusz Szabelski (1 shared paper)Ireneusz Piwoński (1 shared paper)Sylwia Michlewska (1 shared paper)
In The Last Decade
Anna Lichota
13 papers receiving 616 citations
Anna Lichota's Hit Papers
Peers
Comparison fields: 5 of 97
- Toxicology 35
- Internal Medicine 30
- Biochemistry 47
- Complementary and alternative medicine 59
- Pharmacology 53
Countries citing papers authored by Anna Lichota
This map shows the geographic impact of Anna Lichota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lichota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lichota more than expected).
Fields of papers citing papers by Anna Lichota
This network shows the impact of papers produced by Anna Lichota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lichota. The network helps show where Anna Lichota may publish in the future.
Co-authors
The 24 scholars most cited alongside Anna Lichota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anticancer Activity of Natural Compounds from Plant and Marine Environment Hit paper breakdown → | 2018 | 358 |
| 2 | 2019 | 83 | |
| 3 | 2020 | 56 | |
| 4 | 2016 | 39 | |
| 5 | 2020 | 22 | |
| 6 | 2020 | 18 | |
| 7 | 2022 | 18 | |
| 8 | 2024 | 16 | |
| 9 | 2016 | 13 | |
| 10 | 2019 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2025 | 0 |
About Anna Lichota
Anna Lichota is a scholar working on Organic Chemistry, Molecular Biology, Internal Medicine, Biomedical Engineering and Pharmacology, having authored 14 papers that have together received 634 indexed citations. Recurring topics across this work include Fullerene Chemistry and Applications (4 papers), Graphene and Nanomaterials Applications (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Microbial Metabolites in Food Biotechnology (1 paper), Quinazolinone synthesis and applications (1 paper), Photochemistry and Electron Transfer Studies (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Toxicology (35 citations), Internal Medicine (30 citations), Biochemistry (47 citations), Complementary and alternative medicine (59 citations) and Pharmacology (53 citations). Anna Lichota has collaborated with scholars based in Poland, Germany and China. Frequent co-authors include Krzysztof Gwoździński, Łukasz Gwoździński, Anita Krokosz, Eligia M. Szewczyk, Jacek Grębowski, Mariusz Szabelski, Ireneusz Piwoński, Sylwia Michlewska, Monika Sienkiewicz and Łukasz Łopusiewicz. Their work appears in journals such as International Journal of Molecular Sciences, European Journal of Medicinal Chemistry, Microbiological Research, Fermentation and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.